Host and viral factors that determine the clinical outcome of hepatitis C virus genotype 3a infection
<p>HCV infects 170 million persons worldwide and is a serious global health problem. Genotype-3a is the dominant genotype in newly diagnosed infections within the UK and has a high response rate to interferon therapy, with up to 70% patients achieving a sustained virological response (SVR). Th...
Prif Awduron: | Humphreys, I, Isla S. Humphreys |
---|---|
Awduron Eraill: | Barnes, E |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
2011
|
Pynciau: |
Eitemau Tebyg
-
Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
gan: Hennig, B, et al.
Cyhoeddwyd: (2008) -
Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
gan: Antrobus, R
Cyhoeddwyd: (2014) -
Use of genome wide expression profiles in analysis of T cell dysfunction in Hepatitis C virus infection
gan: Gupta, P
Cyhoeddwyd: (2014) -
Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
gan: Kelly, C
Cyhoeddwyd: (2013) -
Aspects to T-cell phenotype during infection with HIV, CMV and Hepatitis C virus
gan: Northfield, J
Cyhoeddwyd: (2008)